Pertussis vaccine in the US by the end of 1985. In response, Congress passed the National Childhood Vaccine Injury Act (NCVIA) in 1986, establishing a federal no-fault system to compensate victims of injury caused by recommended vaccines. Concerns about side effects led Sato to introduce an even safer acellular vaccine for Japan in 1981 that was approved in the US in 1992 for use in the combination DTaP vaccine. The acellular vaccine has a rate of adverse events similar to that of a Td vaccine (a tetanus-diphtheria vaccine containing no pertussis vaccine). Pertussis vaccine Pertussis vaccine is a vaccine that protects against
White line disease White line disease White line disease (also known as seedy toe) is a fungal infection of the horse's hoof. As the name suggests, it attacks the white line, which connects the sole to the hoof wall. It is sometimes mistaken for hoof wall separation disease, but is not to be confused because it is not genetic nor as severe. White line disease changes the typical light color of the white line to a black or dark gray color. It may also give off a foul odor. Lameness is often not present unless the disease is advanced. The disease may locate